Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 06.05.2026 FTMO.LN IE000CY30YV9 3,050,002.00 USD 90,915,640.75 29.808 ...
-
LaVoie Strategic Communications Group, Inc. Launches New Platform to Support High-Stakes Healthcare and Government Communications
BOSTON & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--LaVoie launches integrated platform supporting healthcare and government organizations in high-stakes communications environments....
-
Be a Part of the Story: “America at 250: Direct Selling, An All-American Story” Calls on Sellers to Protect Their Right to Build on Their Own Terms
WASHINGTON--(BUSINESS WIRE)--To mark America’s 250th anniversary, the Direct Selling Association (DSA) has released a video,“America at 250: Direct Selling, An All-American Story,“ to celebrate direct selling’s place in the American story. At a time when policymakers in Washington and the states are deciding how independent work will be defined, DSA is asking direct sellers across the country to submit their stories to DSA and explain why they choose independence over traditional employment. “A...
-
Screening 4+ Million People Daily, Evolv Technology Introduces “Screened by Evolv™” Seal
WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technology (NASDAQ: EVLV), a leader in AI-powered weapons detection, screens approximately four million people each day to help prevent weapons from entering venues where they are prohibited. Since 2021, Evolv customers have used the Evolv Express® system to tag over 1.7 million weapons, helping to prevent those weapons from entering the places where people live, work, learn and play. Today, Evolv announces the launch of its new Screened by Evolv™ seal ava...
-
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today provided an update following the recent Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) to the Biologics License Application (BLA) for tabelecleucel (tab-...
-
Charles River Associates (CRA) Reports Financial Results for the First Quarter of 2026
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced financial results for the fiscal first quarter ended April 4, 2026. “Maintaining the momentum of a record fiscal 2025, CRA continued its strong performance into the first quarter of fiscal 2026 as revenue increased by 10.5% year over year to $201.0 million,” said Paul Maleh, CRA’s President and Chief Executive Officer. “This re...
-
Butterfly Network to Present at the Bank of America Securities 2026 Global Healthcare Conference
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), today announced that the company will participate at the Bank of America Securities 2026 Global Healthcare Conference. Joseph DeVivo, President, Chief Executive Officer & Chairman and John Doherty, EVP, Chief Financial Officer will present at 4:35 PM PT on May 12, 2026, and host one-on-one investor meetings throughout the day. A webcast of the presentation will be available in the Events &...
-
BlackRock TCP Capital Corp. Announces First Quarter 2026 Financial Results Including Net Investment Income of $0.22 Per Share; Declares a Second Quarter Dividend of $0.17 Per Share
SANTA MONICA, Calif.--(BUSINESS WIRE)--BlackRock TCP Capital Corp. (“we,” “us,” “our,” “TCPC” or the “Company”), a business development company (NASDAQ: TCPC), today announced its financial results for the first quarter ended March 31, 2026 and filed its Form 10-Q with the U.S. Securities and Exchange Commission. FINANCIAL HIGHLIGHTS On a GAAP basis, net investment income for the quarter ended March 31, 2026 was $18.5 million, or $0.22 per share on a diluted basis, which exceeded the regular di...
-
Intellicheck CEO Bryan Lewis To Present at the Sidoti Micro-Cap Virtual Conference on May 21
MELVILLE, N.Y.--(BUSINESS WIRE)--Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company delivering proprietary on-demand digital and physical identity validation solutions, today announced that CEO Bryan Lewis will present at the Sidoti Micro-Cap Virtual Conference taking place on May 20-21, 2026. Joining him at the conference will be CFO Adam Sragovicz. The presentation will begin at 10:45 a.m. EDT on Thursday, May 21 st. Intellicheck CEO Lewis and CFO Sragovicz will also host...
-
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings
MAASTRICHT, Netherlands & YOKNEAM, Israel--(BUSINESS WIRE)--Rapid Medical reports DISTALS trial results showing the safety and efficacy of TIGERTRIEVER 13 in distal ischemic stroke, with encouraging outcomes....